Sibutramine pharmacokinetics in young and elderly healthy subjects
โ Scribed by I. D. Hind; J. E. Mangham; S. P. Ghani; R. E. Haddock; C. J. Garratt; R. W. Jones
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 83 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The single-dose pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were examined in 12 healthy younger subjects < 55 years of age (YNG), 12 elderly subjects > 65 years of age (ELD), 12 patients with biopsy proven hepatic cirrhosis
Pharmacokinetic (PK) parameters for terbinaยฎne were assessed in 15 elderly and 15 young healthy subjects randomized to receive 250 mg Lamisil 1 once daily for 15 d in a two-period, two-treatment, two-sequence, crossover (fed versus fasted) design within age groups. On each treatment day except days